Last reviewed · How we verify

NCT05922618: (PeCFoA)

Pulsed Electromagnetic Fields (PEMFS) in Complex Regional Pain Syndrome Type i (CRPS-I) of the Foot (PeCFoA)

Completed NA Last updated 8 December 2025
What this trial tests

NA trial testing I-One in Pain, Joint in 28 participants. Completed in 1 December 2025.

Timeline
1 August 2023
Primary endpoint
1 August 2025
1 December 2025

Quick facts

Lead sponsorAzienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment28
Start date1 August 2023
Primary completion1 August 2025
Estimated completion1 December 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Who can join

18 and older, any sex, with Pain, Joint or Complex Regional Pain Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators hypothesize that the association of I-ONE® therapy with standard rehabilitation treatment can optimize the clinical and functional recovery of patients with pulsed electromagnetic fields (PEMFs) (I-ONE® therapy) of the foot or ankle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05922618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing